DRE Quality Assurance & Improvement 2

Question 1

When a DRE's evaluation is later found to be inconsistent with toxicology results, what is the MOST appropriate quality assurance response?

Accepted Answer

Conduct a case review to identify potential training or procedural gaps

Answer

Case reviews of inconsistent outcomes are a core QA tool for identifying systemic issues and improving future DRE performance.

Question 2

Which metric is MOST useful for tracking the overall accuracy of a DRE program over time?

Accepted Answer

Percentage of DRE drug category opinions confirmed by toxicology

Answer

Toxicology confirmation rates directly measure how accurately DREs identify drug categories, making it the primary accuracy metric.

Question 3

A DRE supervisor notices that one evaluator consistently misses CNS depressant indicators. The BEST corrective action is:

Accepted Answer

Provide targeted retraining focused on CNS depressant recognition

Answer

Targeted retraining addresses the specific knowledge or skill gap without the unnecessary disruption of full recertification.

Question 4

In the context of DRE QA, a 'blind review' of a Drug Influence Report (DIR) means:

Accepted Answer

The reviewer reads the DIR without knowing the toxicology results

Answer

A blind review prevents confirmation bias by ensuring the reviewer assesses the DIR's quality independent of the known toxicology outcome.

Question 5

Which of the following represents a systemic QA issue rather than an individual DRE error?

Accepted Answer

Multiple DREs across a region consistently fail to identify inhalants

Answer

When the same error appears across multiple evaluators, it signals a systemic training or procedural deficiency rather than individual fault.

(DRE) Drug Recognition Expert Certification Practice Test